HomeCHRS • NASDAQ
Coherus Biosciences Inc
add
$0.78
2.09%
Pre-market:(0.00%)0.00
$0.78
Closed: Jun 4, 5:00:49 AM UTC-4 · USD · NASDAQ · Disclaimer
In the news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 7.60M | 229.25% |
Operating expense | 50.38M | -13.22% |
Net income | -56.57M | -154.99% |
Net profit margin | -744.43 | -116.70% |
Earnings per share | -0.35 | -9.37% |
EBITDA | -44.39M | 20.28% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 82.41M | -68.28% |
Total assets | 371.07M | -51.40% |
Total liabilities | 554.54M | -34.40% |
Total equity | -183.47M | — |
Shares outstanding | 115.93M | — |
Price to book | -0.48 | — |
Return on assets | -27.72% | — |
Return on capital | -80.36% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -56.57M | -154.99% |
Cash from operations | -25.83M | 44.78% |
Cash from investing | -17.49M | -108.62% |
Cash from financing | -264.00K | -129.76% |
Net change in cash | -43.58M | -127.78% |
Free cash flow | -74.89M | -998.41% |
Previous close
$0.77
Day range
$0.74 - $0.80
Year range
$0.66 - $2.43
Market cap
90.19M USD
Avg Volume
1.50M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2010
Headquarters
Website
Employees
221
